Vulinacimab (Anti-VEGFR2 / KDR / CD309)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2250342-36-8
HLX-06
C00819-1mg
Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Beschrijving
Vulinacimab (Anti-VEGFR2 / KDR / CD309) Beschikbaar in 1 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03Low – 10 mg
10 mg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03High – 10 mg
10 mg
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Disc Membrane Hydrophobic PTFE, 0.22μm
CPTB14222
50 PCS
Rat Serum Albumin
CSB-NP000101r-01
1 mg
Denhardt's Solution (50X)
EC-915
50 mL
FKBP4, ID (FK506-binding Protein 4, Peptidyl-prolyl cis-trans Isomerase FKBP4, PPIase FKBP4, Rotamase, HSP-binding Immunophilin, HBI, FKBP52 Protein, 52kD FK506-binding Protein, 52kD FKBP, FKBP-52, 59kD Immunophilin, FKBP59, p59 Protein, FKBP-4, FKBP52)
MBS623609-01
0.2 mL
Recent gezochte producten
Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg
E030010N08Rik (m) -PR
sc-143217-PR
10 µM - 20 µL
C030019I05Rik siRNA (m)
sc-141806
10 µM
E030019B06Rik (m) -PR
sc-143221-PR
10 µM - 20 µL
C030019I05Rik (m) -PR
sc-141806-PR
10 µM - 20 µL
D030016E14Rik (m) -PR
sc-142768-PR
10 µM - 20 µL
Compound N003-0017
T131382-01
1 mg
Compound N003-0017
MBS5796320
Inquire